ArticleJournal of the American Chemical Society2026
Stereoselective Epimerization of 1,3-Diols Using a Chiral Hydrogen Atom Abstraction Catalyst.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The 1,3-diol unit is an extremely important functional group motif, and significant effort has gone into development of methods to access it with definition of relative and absolute stereochemistry. Conventionally, stereochemical complexity is built up in a stepwise manner alongside functional group interconversion. It is interesting to consider an unconventional approach whereby the diol may be synthesized nonselectively and the stereoisomers "descrambled" by a chiral catalyst in a subsequent step. We report studies toward this goal using a cinchona alkaloid-derived hydrogen atom abstraction catalyst. This catalyst permits selective hydrogen atom abstraction from a given stereoisomer out of, in some cases three or four, depending on diol substitution. The relative rates of abstraction from different stereoisomers determine the ultimate product outcome after hydrogen atom delivery from an achiral thiol. Symmetrical 1,3-diols participate in a kinetic resolution process whereby one enantiomer is converted to the meso diastereomer with extremely high selectivity, a rare example of a kinetic resolution involving conversion of one enantiomer to an achiral diastereomer. Nonsymmetrical 1,3-diols exhibit different outcomes depending on substitution, and their behavior is systematically explored. Notably, sterically differentiated substrates can allow high ee of both syn and anti diastereomers to be achieved from racemic starting material. On the basis of mechanistic studies, a unified rationalization of the behavior of 1,3-diols of various types with our catalyst is presented, and we additionally evaluate the analogous chiral 1,2-diols, uncovering promising outcomes with nonsymmetrical diols.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.